Strategic Acquisitions to Drive Production Sales of Measurement Technology in Downstream Processing

Measurement Technology in Downstream Processing Market

Single-use has been the most preferable modality in the market for measurement technology in downstream processing. The production sales of this technology will stimulate significantly with the growing adoption in biopharmaceutical companies across the globe. Increase in the demand for continuous feedback and high precision sensors have been contributing significantly towards the growth of global market in the forthcoming years. There has been considerable increase in the cases related to chronic diseases, which in turn is growing the production sales of measurement technology in downstream processing across the globe.

A recent report projects that the market for measurement technology in downstream processing will grow at a healthy 6.1% CAGR over the projected period, 2017-2027, for reaching a valuation of approximately US$ 6,827.9Mn by 2027-end. Companies namely Thermo Fisher Scientific, Sartorius AG, Mettler-Toledo International, Inc., Broadley-James Corporation, PreSens Precision Sensing GmbH, Hamilton Company and Applikon Biotechnology, Inc. among others are likely to observe a significant growth across the globe. Key players and manufacturers are planning to concentrate on the marketing schemes such as product advancements and innovations as well as expanding their product portfolio.

Thermo Fisher Scientific Acquires Finesse Solutions

Thermo Fisher Scientific lately acquired Finesse Solutions, which is the company’s long-term distributor of the control and measurement solutions for the purpose of bioprocessing applications. Single-use technologies of Thermo Fisher Scientific has been significantly beneficial for Finesse Solutions, as it would help the company in strengthening their position in high-level bioproduction market.

The smart technology of Finesse Solutions delivers a wide-ranging data management software as well as bioreactor sensors and controllers, which enables drugmakers and bioprocessing firms to configure biomanufacturing procedures from labscale to the cGMP-compliant manufacturing. Key players and manufacturers must note that this deal is expected to be highly beneficial for Thermo Fisher Scientific, due to which, heavy investments in this leading company can help in strengthening the position in the market for measurement technology in downstream processing across the globe. Furthermore, Thermo Fisher Scientific is looking for further opportunities for entering into strategic and beneficial mergers and acquisitions for the expansion of their business.

Exclusive Benefits of Acquiring Finesse Solutions

Thermo Fisher Scientific has turned out to be the only bioproduction distributor, which provides products that spans the complete workflow. In addition, the company also offers software and process automation, in order to combine the technology and make it highly beneficial for the end-users.

Finesse Solutions is witnessed to pick up an innovative and fresh approach that will highly bring in the attention of existing as well as emerging customers. The platform of Finesse Solutions incorporates seamlessly with the consumable and hardware solutions of Thermo Fisher Scientific. Finesse Solutions hold the quality of spanning downstream and upstream processing and from the lab to manufacturing scale that gels up well with the product line of Thermo Fisher Scientific. Key players and manufacturers can focus on the point that SmartFactory level will be combining the superior products altogether in a complete workflow solution that would be extremely beneficial for the end-users.

A sample of this report is available upon request @

About the Author

Surbhi Gupta

Surbhi Gupta is an experienced healthcare consultant, with over six years of experience in global pharmaceutical industry. She comes with a vast experience in healthcare consulting and pharmaceutical business research and has done multiple market access, competitive intelligence and market estimation studies, with a forte in business reporting. Since her Master’s in pharmaceutical management, Surbhi has covered and written about the latest developments in the pharmaceutical sector. To keep herself abreast she devotes most her time in reading and analyzing various industry updates. She loves travelling and listening to music in her free time.

Leave a Reply

Your email address will not be published. Required fields are marked *

You may also like these